|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 9/05/19 American Renal Assocs Holdin… Inc 10-K 12/31/18 129:43M |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 3.58M
2: EX-4.1 Instrument Defining the Rights of Security Holders HTML 80K
5: EX-10.11 Material Contract HTML 46K
6: EX-10.12 Material Contract HTML 55K
3: EX-10.6 Material Contract HTML 46K
4: EX-10.7 Material Contract HTML 55K
7: EX-21.1 Subsidiaries List HTML 100K
8: EX-23.1 Consent of Experts or Counsel HTML 34K
9: EX-31.1 Certification -- §302 - SOA'02 HTML 41K
10: EX-31.2 Certification -- §302 - SOA'02 HTML 41K
11: EX-32.1 Certification -- §906 - SOA'02 HTML 36K
12: EX-32.2 Certification -- §906 - SOA'02 HTML 36K
98: R1 Document and Entity Information HTML 69K
23: R2 Consolidated Balance Sheets HTML 156K
65: R3 Consolidated Balance Sheets (Parenthetical) HTML 55K
110: R4 Consolidated Statements of Operations HTML 117K
100: R5 Consolidated Statements of Comprehensive (Loss) HTML 60K
Income
25: R6 Consolidated Statements of Changes in Equity HTML 194K
67: R7 Consolidated Statements of Changes in Equity HTML 38K
(Parenthetical)
112: R8 Consolidated Statements of Cash Flows HTML 165K
96: R9 Basis of Presentation and Organization HTML 41K
84: R10 Summary of Significant Accounting Policies HTML 131K
128: R11 Restatement of Consolidated Financial Statements HTML 626K
55: R12 Initial Public Offering HTML 62K
41: R13 Cash HTML 49K
85: R14 Prepaid Expenses and Other Current Assets HTML 45K
129: R15 Acquisitions and Divestitures HTML 64K
56: R16 Fair Value Measurements HTML 147K
42: R17 Property and Equipment HTML 60K
86: R18 Intangible Assets and Goodwill HTML 69K
127: R19 Accrued Expenses and Other Current Liabilities HTML 61K
61: R20 Variable Interest Entities HTML 42K
20: R21 Noncontrolling Interests Subject to Put Provisions HTML 79K
87: R22 Changes in Ownership Interest in Consolidated HTML 53K
Subsidiaries
101: R23 Debt HTML 114K
62: R24 Leases HTML 74K
21: R25 Income Taxes HTML 138K
88: R26 Loss Per Share HTML 59K
102: R27 Stock-Based Compensation HTML 119K
60: R28 Related Party Transactions HTML 46K
22: R29 Commitments and Contingencies HTML 42K
45: R30 Certain Legal Matters and Other Matters HTML 63K
58: R31 Employee Benefit Plan HTML 37K
126: R32 Concentrations HTML 38K
83: R33 Subsequent Events HTML 56K
44: R34 Selected Quarterly Financial Data (Unaudited) HTML 3.06M
57: R35 Schedule Ii - Valuation and Qualifying Accounts HTML 52K
125: R36 Summary of Significant Accounting Policies HTML 152K
(Policies)
82: R37 Summary of Significant Accounting Policies HTML 53K
(Tables)
43: R38 Restatement of Consolidated Financial Statements HTML 3.58M
(Tables)
59: R39 Cash (Tables) HTML 47K
27: R40 Prepaid Expenses and Other Current Assets (Tables) HTML 46K
64: R41 Acquisitions and Divestitures (Tables) HTML 47K
113: R42 Fair Value Measurements (Tables) HTML 119K
97: R43 Property and Equipment (Tables) HTML 56K
26: R44 Intangible Assets and Goodwill (Tables) HTML 73K
63: R45 Accrued Expenses and Other Current Liabilities HTML 62K
(Tables)
111: R46 Noncontrolling Interests Subject to Put Provisions HTML 73K
(Tables)
95: R47 Changes in Ownership Interest in Consolidated HTML 54K
Subsidiaries (Tables)
24: R48 Debt (Tables) HTML 78K
66: R49 Leases (Tables) HTML 68K
49: R50 Income Taxes (Tables) HTML 139K
32: R51 Loss Per Share (Tables) HTML 58K
80: R52 Stock-Based Compensation (Tables) HTML 105K
120: R53 Subsequent Events (Tables) HTML 45K
50: R54 Selected Quarterly Financial Data (Unaudited) HTML 3.64M
(Tables)
33: R55 Basis of Presentation and Organization (Details) HTML 56K
81: R56 Summary of Significant Accounting Policies HTML 168K
(Details)
122: R57 Summary of Significant Accounting Policies HTML 48K
Schedule of Revenue (Details)
47: R58 Restatement of Consolidated Financial Statements - HTML 216K
Restated Consolidated Balance Sheets (Details)
36: R59 Restatement of Consolidated Financial Statements - HTML 57K
Restated Consolidated Balance Sheet
(Parenthetical) (Details)
89: R60 Restatement of Consolidated Financial Statements - HTML 192K
Restated Consolidated Statements of Operations
(Details)
106: R61 Restatement of Consolidated Financial Statements - HTML 77K
Restated Consolidated Statements of Comprehensive
Income (Details)
68: R62 Restatement of Consolidated Financial Statements - HTML 264K
Restated Consolidated Statements of Cash Flows
(Details)
28: R63 Initial Public Offering (Details) HTML 172K
92: R64 Cash (Details) HTML 48K
109: R65 Prepaid Expenses and Other Current Assets HTML 46K
(Details)
71: R66 Acquisitions and Divestitures - Acquisitions HTML 80K
(Details)
31: R67 Acquisitions and Divestitures - Divestitures HTML 63K
(Details)
93: R68 Fair Value Measurements - Narrative (Details) HTML 44K
104: R69 Fair Value Measurements - Schedule of fair value HTML 94K
(Details)
117: R70 Fair Value Measurements - Fair value rollforward HTML 44K
of tax receivable agreement liability (Details)
77: R71 Property and Equipment (Details) HTML 82K
40: R72 Intangible Assets and Goodwill - Schedule of HTML 60K
intangible assets (Details)
54: R73 Intangible Assets and Goodwill - Estimated annual HTML 52K
amortization expense (Details)
114: R74 Intangible Assets and Goodwill - Changes in the HTML 45K
value of goodwill (Details)
74: R75 Accrued Expenses and Other Current Liabilities HTML 64K
(Details)
37: R76 Variable Interest Entities (Details) HTML 38K
51: R77 Noncontrolling Interests Subject to Put Provisions HTML 69K
(Details)
119: R78 Changes in Ownership Interest in Consolidated HTML 56K
Subsidiaries (Details)
73: R79 Debt - Schedule of long term-term debt (Details) HTML 94K
116: R80 Debt Debt - Scheduled maturities of long-term debt HTML 55K
(Details)
76: R81 Debt - Narrative (Details) HTML 226K
39: R82 Leases - Narrative (Details) HTML 57K
53: R83 Leases - Schedule of Future Minimum Lease Payments HTML 121K
(Details)
115: R84 Income Taxes - Provision (Benefit) for Income HTML 64K
Taxes (Details)
75: R85 Income Taxes - Significant components of deferred HTML 84K
tax assets and liabilities (Details)
38: R86 Income Taxes Income Taxes - Narrative (Details) HTML 59K
52: R87 Income Taxes - Reconciliation of the federal HTML 56K
statutory rate (Details)
118: R88 Income Taxes - Gross amounts of unrecognized tax HTML 43K
benefits (Details)
72: R89 Loss Per Share (Details) HTML 64K
90: R90 Stock-Based Compensation - Narrative (Details) HTML 100K
107: R91 Stock-Based Compensation - Equity Grants, HTML 42K
Assumptions and Activity (Details)
69: R92 Stock-Based Compensation - Assumptions used for HTML 55K
options granted (Details)
29: R93 Stock-Based Compensation - Stock option activity HTML 103K
(Details)
91: R94 Stock-Based Compensation - Restricted stock HTML 60K
activity (Details)
108: R95 Related Party Transactions (Details) HTML 75K
70: R96 Commitments and Contingencies (Details) HTML 46K
30: R97 Certain Legal Matters and Other Matters (Details) HTML 79K
94: R98 Employee Benefit Plan (Details) HTML 36K
105: R99 Concentrations (Details) HTML 35K
123: R100 Subsequent Events - Acquisitions (Details) HTML 77K
78: R101 Subsequent Events - Narrative (Details) HTML 95K
34: R102 Selected Quarterly Financial Data (Unaudited) HTML 73K
(Details)
46: R103 Selected Quarterly Financial Data (Unaudited) - HTML 216K
Condensed Consolidated Balance Sheets (Details)
124: R104 Selected Quarterly Financial Data (Unaudited) - HTML 57K
Condensed Consolidated Balance Sheets
(Parenthetical) (Details)
79: R105 Selected Quarterly Financial Data (Unaudited) - HTML 198K
Condensed Consolidated Statements of Operations
(Details)
35: R106 Selected Quarterly Financial Data (Unaudited) - HTML 77K
Consolidated Statements of Comprehensive Income
(Loss) (Details)
48: R107 Selected Quarterly Financial Data (Unaudited) - HTML 264K
Condensed Consolidated Statements of Cash Flows
(Details)
121: R108 Schedule Ii - Valuation and Qualifying Accounts HTML 43K
(Details)
99: XML IDEA XML File -- Filing Summary XML 226K
19: EXCEL IDEA Workbook of Financial Reports XLSX 222K
13: EX-101.INS XBRL Instance -- ara-20181231 XML 14.05M
15: EX-101.CAL XBRL Calculations -- ara-20181231_cal XML 394K
16: EX-101.DEF XBRL Definitions -- ara-20181231_def XML 1.30M
17: EX-101.LAB XBRL Labels -- ara-20181231_lab XML 2.61M
18: EX-101.PRE XBRL Presentations -- ara-20181231_pre XML 1.92M
14: EX-101.SCH XBRL Schema -- ara-20181231 XSD 266K
103: ZIP XBRL Zipped Folder -- 0001498068-19-000060-xbrl Zip 711K
| Exhibit |
1. | I have reviewed this Annual Report on Form 10-K for the year ended December 31, 2018 of American Renal Associates Holdings, Inc.
(the “registrant”); |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows
of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) | Designed
such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
(b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
(c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
(d) | Disclosed in this report any
change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The
registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
(a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record,
process, summarize and report financial information; and |
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
/s/ Mark Herbers |
Interim Chief Financial Officer |
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed as of: | 9/5/19 | 10-Q, 8-K | ||
| Filed on: | 9/4/19 | 10-Q | ||
| For Period end: | 12/31/18 | NT 10-K | ||
| List all Filings | ||||